#$%^&*AU2019219733A120190905.pdf#####C: Interwoven NRPortbl DCC BAS 19165154_1.docx - 8/8/19 Abstract The present disclosure relates to pantothenate derivatives for the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), pharmaceutical compositions containing such compounds, and their use in treatment of neurologic disorders.